Fifth Era Acquisition Corp I
FERAR · NASDAQ
FERAR key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 35.85K
- Volume
- 230.51K
- Open price
- $0.23
- High today
- $0.2318
- Low today
- $0.2265
- 52 Week high
- $0.505
- 52 Week low
- $0.1915
Fifth Era Acquisition Corp I (FERAR) at a glance
As of Oct 22, 2026, Fifth Era Acquisition Corp I (FERAR) shares are priced at $0.23, giving the company a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.2265 and $0.2318. The current price is 1.5% above the day's low and 0.8% below its high.
Volume so far is 230.51K shares, above the average of 35.85K shares a day.
Over the past year Fifth Era Acquisition Corp I has ranged from $0.1915 to $0.505, and now sits 12% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.